How useful is kidney biopsy for the management of glomerulopathies in the elderly?
Elderly
Glomerulopathy
Kidney biopsy
Kidney outcome
Journal
Journal of nephrology
ISSN: 1724-6059
Titre abrégé: J Nephrol
Pays: Italy
ID NLM: 9012268
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
01
04
2022
accepted:
29
07
2022
pubmed:
10
9
2022
medline:
30
11
2022
entrez:
9
9
2022
Statut:
ppublish
Résumé
The use of kidney biopsy in elderly individuals is still matter of discussion. The purpose of this study is to assess the utility of kidney biopsy for the management of glomerulopathies in an Eastern European cohort, targeting patients older than 65 years. This retrospective study included 875 adults (147 older than 65 years), with biopsy-proven glomerulopathies, followed up for 71.1 (95% CI 68.2-73.9) months. The primary endpoint was chronic renal replacement therapy initiation. Statistical evaluation was performed with IBM SPSS software version 20, Analyse-it, and SAS Studio. The Kaplan-Meier method was used to estimate the time to death and the log-rank test was used for comparisons. The multivariate Cox proportional hazard analysis was used to evaluate the risk of death. Secondary glomerulopathies were more frequent in patients aged > 65 years (52.4% vs. 41.9%, p = 0.004). Membranous nephropathy and amyloidosis were the most frequent primary and secondary glomerulopathies in this age group. Kidney biopsy complications were low (< 4%) in both age groups. In 42% of the elderly, the result of biopsy guided the immunosuppressive therapy. While the all-cause mortality rate was higher (OR 4.2; 95% CI 2.7-6.7; p < 0.0001) in elderly individuals, the rate of renal replacement therapy initiation was similar (31.3 vs 26%; p = 0.1) in both age groups. In the competitive risk analysis, kidney survival was similar irrespective of age [CIF 0.4 (95% CI 0.26-0.53) vs. 0.34 (95% CI 0.28-0.39), p = 0.08]. However, after adjusting for the confounding factors, younger age was associated with an increased risk of renal replacement therapy (HR = 1.57, p = 0.01), along with secondary glomerulopathies. The diagnosis of an underlying glomerulopathy guided the therapy in almost one-half of the elderly patients who underwent a kidney biopsy, provided important prognostic information and had a low complications rate; kidney biopsy may therefore be considered a safe, reliable procedure in the management of glomerulopathies, even in patients over 65 years of age.
Sections du résumé
BACKGROUND
The use of kidney biopsy in elderly individuals is still matter of discussion. The purpose of this study is to assess the utility of kidney biopsy for the management of glomerulopathies in an Eastern European cohort, targeting patients older than 65 years.
METHODS
This retrospective study included 875 adults (147 older than 65 years), with biopsy-proven glomerulopathies, followed up for 71.1 (95% CI 68.2-73.9) months. The primary endpoint was chronic renal replacement therapy initiation. Statistical evaluation was performed with IBM SPSS software version 20, Analyse-it, and SAS Studio. The Kaplan-Meier method was used to estimate the time to death and the log-rank test was used for comparisons. The multivariate Cox proportional hazard analysis was used to evaluate the risk of death.
RESULTS
Secondary glomerulopathies were more frequent in patients aged > 65 years (52.4% vs. 41.9%, p = 0.004). Membranous nephropathy and amyloidosis were the most frequent primary and secondary glomerulopathies in this age group. Kidney biopsy complications were low (< 4%) in both age groups. In 42% of the elderly, the result of biopsy guided the immunosuppressive therapy. While the all-cause mortality rate was higher (OR 4.2; 95% CI 2.7-6.7; p < 0.0001) in elderly individuals, the rate of renal replacement therapy initiation was similar (31.3 vs 26%; p = 0.1) in both age groups. In the competitive risk analysis, kidney survival was similar irrespective of age [CIF 0.4 (95% CI 0.26-0.53) vs. 0.34 (95% CI 0.28-0.39), p = 0.08]. However, after adjusting for the confounding factors, younger age was associated with an increased risk of renal replacement therapy (HR = 1.57, p = 0.01), along with secondary glomerulopathies.
CONCLUSION
The diagnosis of an underlying glomerulopathy guided the therapy in almost one-half of the elderly patients who underwent a kidney biopsy, provided important prognostic information and had a low complications rate; kidney biopsy may therefore be considered a safe, reliable procedure in the management of glomerulopathies, even in patients over 65 years of age.
Identifiants
pubmed: 36083532
doi: 10.1007/s40620-022-01427-5
pii: 10.1007/s40620-022-01427-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2301-2312Informations de copyright
© 2022. The Author(s) under exclusive licence to Italian Society of Nephrology.
Références
Day ES. New publication (2019) Ageing Europe – looking at the lives of older people. https://doi.org/10.2785/628105
Stevens LA, Viswanathan G, Weiner DE, CKD and ESRD in the Elderly (2010) Current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis. https://doi.org/10.1053/j.ackd.2010.03.010
doi: 10.1053/j.ackd.2010.03.010
pubmed: 20610356
pmcid: 3160131
Glaudet F, Hottelart C, Allard J et al (2013) The clinical status and survival in elderly dialysis: example of the oldest region of France. BMC Nephrol. https://doi.org/10.1186/1471-2369-14-131
doi: 10.1186/1471-2369-14-131
pubmed: 23800023
pmcid: 3694468
Nair R, Bell JM, Walker PD (2004) Renal biopsy in patients aged 80 years and older. Am J Kidney Dis. https://doi.org/10.1053/j.ajkd.2004.05.044
doi: 10.1053/j.ajkd.2004.05.044
pubmed: 15384012
Mohamed N, John R (2011) Use of renal biopsy in the elderly. Int Urol Nephrol. https://doi.org/10.1007/s11255-010-9874-9
doi: 10.1007/s11255-010-9874-9
pubmed: 21113798
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. https://doi.org/10.1016/0021-9681(87)90171-8
doi: 10.1016/0021-9681(87)90171-8
pubmed: 3805232
Austin PC, Fine JP (2017) Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med. https://doi.org/10.1002/sim.7501
doi: 10.1002/sim.7501
pubmed: 29529711
pmcid: 6886075
Yokoyama H, Sugiyama H, Sato H et al (2012) Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol. https://doi.org/10.1007/s10157-012-0673-8
doi: 10.1007/s10157-012-0673-8
pubmed: 23100177
Haas M,Spargo BH, Wit EC, Meehan SM (2000) Etiologies and outcome of acute renal insufficiency in older adults: A renal biopsy study of 259 cases. Am J Kidney Dis. https://doi.org/10.1016/S0272-6386(00)70196-X
doi: 10.1016/S0272-6386(00)70196-X
pubmed: 11096055
Davison AM, Johnston PA (1996) Glomerulonephritis in the elderly. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/11.supp9.34
doi: 10.1093/ndt/11.supp9.34
pubmed: 8918607
Yang F, Li B, Cui W et al (2015) A clinicopathological study of renal biopsies from 288 elderly patients: analysis based on 4,185 cases. Int Urol Nephrol. https://doi.org/10.1007/s11255-014-0895-7
doi: 10.1007/s11255-014-0895-7
pubmed: 26685887
Zhu P, Zhou FD, Zhao MH (2014) The renal histopathology spectrum of elderly patients with kidney diseases: a study of 430 patients in a single chinese center. Medicine. https://doi.org/10.1097/MD.0000000000000226
doi: 10.1097/MD.0000000000000226
pubmed: 25549238
pmcid: 4280122
Bagchi S, Mittal P, Singh G et al (2016) Pattern of biopsy-proven kidney disease in the elderly in a tertiary care hospital in India: a clinicopathological study. Int Urol Nephrol. https://doi.org/10.1007/s11255-015-1193-8
doi: 10.1007/s11255-015-1193-8
pubmed: 26759328
Verde E, Quiroga B, Rivera F, López-Gómez JM (2012) Renal biopsy in very elderly patients: data from the Spanish Registry of Glomerulonephritis. Am J Nephrol. https://doi.org/10.1159/000336307
doi: 10.1159/000336307
pubmed: 22343659
Moutzouris DA, Herlitz L, Appel GB et al (2009) Renal biopsy in the very elderly. Clin J Am Soc Nephrol. https://doi.org/10.2215/CJN.00990209
doi: 10.2215/CJN.00990209
pubmed: 19808225
pmcid: 2689880
Helvacı Ö, Korucu B, Gonul Iİ et al (2021) Kidney biopsy in the elderly: diagnostic adequacy and yield. Int Urol Nephrol. https://doi.org/10.1007/s11255-020-02640-6
doi: 10.1007/s11255-020-02640-6
pubmed: 32940813
Kohli HS, Jairam A, Bhat A et al (2006) Safety of kidney biopsy in elderly: a prospective study. Int Urol Nephrol. https://doi.org/10.1007/s11255-006-0088-0
doi: 10.1007/s11255-006-0088-0
pubmed: 17318359
Naumovic R, Pavlovic S, Stojkovic D, Basta-Jovanovic G, Nesic V (2009) Renal biopsy registry from a single centre in Ser-bia: 20 years of experience. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/gfn564
doi: 10.1093/ndt/gfn564
pubmed: 18927123
Rivera F, López-Gómez JM, Pérez-García R (2002) Spanish registry of glomerulonephritis. Frequency of renal pathology in Spain 1994–1999. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/17.9.1594
doi: 10.1093/ndt/17.9.1594
pubmed: 12401868
Perkowska-Ptasinska A, Deborska-Materkowska D, Bartczak A et al (2016) Kidney disease in the elderly: biopsy based data from 14 renal centers in Poland. BMC Nephrol. https://doi.org/10.1186/s12882-016-0410-8
doi: 10.1186/s12882-016-0410-8
pubmed: 27884116
pmcid: 5123353
Harmankaya O, Okuturlar Y, Kocoglu H et al (2015) Renal biopsy in the elderly: a single-center experience. Int Urol Nephrol. https://doi.org/10.1007/s11255-015-1035-8
doi: 10.1007/s11255-015-1035-8
pubmed: 26135198
Chen Y, Li P, Cui C et al (2016) Biopsy-proven kidney diseases in the elderly: clinical characteristics, renal histopathological spectrum and prognostic factors. J Int Med Res. https://doi.org/10.1177/0300060516660247
doi: 10.1177/0300060516660247
pubmed: 28222633
pmcid: 5536603
Pinçon E, Rioux-Leclercq N, Frouget T, Le Pogamp P, Vigneau C (2010) Renal biopsies after 70 years of age: a retrospective longitudinal study from 2000 to 2007 on 150 patients in Western France. Arch Gerontol Geriatr. https://doi.org/10.1016/j.archger.2010.03.006
doi: 10.1016/j.archger.2010.03.006
pubmed: 20447700
Komatsuda A, Nakamoto Y, Imai H et al (1993) Kidney diseases among the elderly—a clinicopathological analysis of 247 elderly patients. Intern Med. https://doi.org/10.2169/internalmedicine.32.377
doi: 10.2169/internalmedicine.32.377
pubmed: 8400499
O’Hare AM, Choi AI, Bertenthal D et al (2007) Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. https://doi.org/10.1681/ASN.2007040422
doi: 10.1681/ASN.2007040422
pubmed: 17942954
De Nicola L, Minutolo R, Chiodini P et al (2012) The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care. Kidney Int. https://doi.org/10.1038/ki.2012.174
doi: 10.1038/ki.2012.174
pubmed: 22622495